Clinical Trial Update: Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy [NA]

View source ↗

Summary

Completed clinical trial evaluating rosiglitazone's effects on renal hemodynamics and proteinuria in adults with type 2 diabetes and overt diabetic nephropathy;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Type 2 Diabetes, Overt Diabetic Nephropathy | NA | Status: COMPLETED | Results posted: 2011-10-21